These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1867031)

  • 41. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.
    Perry RT; Plowe CV; Koumaré B; Bougoudogo F; Kotloff KL; Losonsky GA; Wasserman SS; Levine MM
    Bull World Health Organ; 1998; 76(1):63-71. PubMed ID: 9615498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of phase contrast microscopy and ordinary serologic methods for detection of specific antibodies to non-agglutinating vibrios in human sera].
    Givental' NI; Gritsenko AN; Podosinnikova LS; Ermol'eva ZV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):54-7. PubMed ID: 4616571
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination.
    Rijpkema SG; Jansen WH; Gielen H; Guinée PA
    Microb Pathog; 1987 Nov; 3(5):365-75. PubMed ID: 2462153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research on V. cholerae anti-antibodies (agglutinating and vibriocidal) in patients affected by cholera-like gastroenteritis. Studies performed during the cholera epidemic occurred in Apulia in August-September 1973].
    Barbuti S; Iandolo E; Rizzo G; Leogrande G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):449-59. PubMed ID: 1084731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
    Morris JG; Losonsky GE; Johnson JA; Tacket CO; Nataro JP; Panigrahi P; Levin MM
    J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Rystsova EA; Reznikov IuB; Matusevich LIa; Nikitina GP; Eliseev IuIu; Adamova GV; Plotnikova MN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):55-8. PubMed ID: 1719716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colonization of Vibrio cholerae among persons in contact with cholera patients.
    Oo KN; Htwe KM; Khine TT
    J Health Popul Nutr; 2001 Mar; 19(1):43-4. PubMed ID: 11394184
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection.
    Lycke N; Svennerholm AM; Holmgren J
    Microb Pathog; 1986 Aug; 1(4):361-71. PubMed ID: 3508492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.
    Lange S; Holmgren J
    Acta Pathol Microbiol Scand C; 1978 Aug; 86C(4):145-52. PubMed ID: 696335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of anticoagulants for serologic assays of cholera vaccination.
    Yang JS; Kang SS; Yun CH; Han SH
    Clin Vaccine Immunol; 2014 Jun; 21(6):854-8. PubMed ID: 24717970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of disease and immunity in cholera: a review.
    Holmgren J; Svennerholm AM
    J Infect Dis; 1977 Aug; 136 Suppl():S105-12. PubMed ID: 197173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The epidemiological aspects of the importation of cholera into the territory of the Uzbek SSR in recent years].
    Mukhamedov SM; Seredin VG; Inzhevatova MV; Kocherovskaia EIu; Shadmanov RK; Kozlov AI; Shmerkevich DL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):58-60. PubMed ID: 2150142
    [No Abstract]   [Full Text] [Related]  

  • 57. Cholera: Immunity and Prospects in Vaccine Development.
    Harris JB
    J Infect Dis; 2018 Oct; 218(suppl_3):S141-S146. PubMed ID: 30184117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Seroepidemiology of cholera in Mexico].
    González-Bonilla C; Valle-Valdez JG; Núñez-León A; Moguel-Pech L; Villanueva-Zamudio A
    Rev Latinoam Microbiol; 1994; 36(4):253-6. PubMed ID: 7701134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Avidity of specific antibodies in the sera of cholera patients and vibrio carriers].
    Bunin KV; Firsanov VI; Parfenova NN; Kravtsov EG; Nechaeva IP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):70-4. PubMed ID: 1015080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].
    Lagos R; Avendaño A; Horwitz I; Prado V; Ferreccio C; Sotomayor V; Losonsky G; Wasserman SS; Cryz S; Kaper JB
    Rev Med Chil; 1993 Aug; 121(8):857-63. PubMed ID: 8296092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.